Log in to save to my catalogue

Fibroblast growth factor 21 for non-alcoholic steatohepatitis

Fibroblast growth factor 21 for non-alcoholic steatohepatitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2157658391

Fibroblast growth factor 21 for non-alcoholic steatohepatitis

About this item

Full title

Fibroblast growth factor 21 for non-alcoholic steatohepatitis

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2018-12, Vol.392 (10165), p.2658-2660

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

FGF21 is a protein produced by the liver, adipose tissue, and pancreas that has variable effects in animals, including reducing sugar intake, increasing insulin sensitivity, browning adipose tissue, and increasing energy expenditure.6 In animal models7 of non-alcoholic steatohepatitis, FGF21 reduced hepatic lipotoxicity and improved liver injury, p...

Alternative Titles

Full title

Fibroblast growth factor 21 for non-alcoholic steatohepatitis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2157658391

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2157658391

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(18)32165-2

How to access this item